On August 13, the Federal Circuit issued a precedential ruling in Allergan v. MSN Laboratories (Case No. 24-1061). This decision reversed the District of Delaware's application of the Federal Circuit precedent in In re:...more
8/22/2024
/ Abbreviated New Drug Application (ANDA) ,
Allergan Inc ,
Double Patent ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Intellectual Property Protection ,
Life Sciences ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Term Adjustment ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents
For many charged with the development of intellectual property portfolios in the life sciences and software industries, navigating the stormy waters of patent eligibility has recently proven difficult. U.S. Supreme Court and...more
6/10/2016
/ Asset Seizure ,
Biotechnology ,
Defend Trade Secrets Act (DTSA) ,
Ex Parte ,
Intellectual Property Protection ,
Life Sciences ,
Misappropriation ,
New Legislation ,
Patent-Eligible Subject Matter ,
Private Right of Action ,
Software ,
Trade Secrets ,
Uniform Trade Secrets Acts ,
USPTO